![Thomas F. Widmann](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Thomas F. Widmann
Direttore/Membro del Consiglio presso
New York Philharmonic
Profilo
Thomas F.
Widmann is the founder of Actelion Ltd. founded in 1999.
He is currently the Director at New York Philharmonic.
His former positions include Chairman-Supervisory Board at Immatics Biotechnologies GmbH from 2004 to 2009, Independent Director at Cancer Genetics, Inc. from 2017 to 2019, Director-Supervisory Board at Trigen Holdings AG in 2009, Director at Symetis SA, and General Partner at Wellington Partners GmbH from 2003 to 2017.
Dr. Widmann's education includes an undergraduate degree from Ruprecht-Karls-Universität Heidelberg and a doctorate from the University of Geneva.
Posizioni attive di Thomas F. Widmann
| Società | Posizione | Inizio |
|---|---|---|
New York Philharmonic
 New York Philharmonic Movies/EntertainmentConsumer Services Provides live theatrical presentations | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Thomas F. Widmann
| Società | Posizione | Fine |
|---|---|---|
| CANCER GENETICS, INC. | Direttore/Membro del Consiglio | 31/05/2019 |
Immatics Biotechnologies GmbH
 Immatics Biotechnologies GmbH BiotechnologyHealth Technology Operates as a bio technology company that develops and delivers T cell redirecting immunotherapies for treatment of cancer | Presidente | 12/11/2012 |
Trigen Holdings AG
 Trigen Holdings AG Miscellaneous Commercial ServicesCommercial Services Develops drugs focusing on thrombosis and vascular dysfunction | Direttore/Membro del Consiglio | 15/12/2009 |
| ACTELION | Fondatore | 01/01/2003 |
| SYMETIS SA | Direttore/Membro del Consiglio | - |
Formazione di Thomas F. Widmann
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
76
Relazioni di 1° grado
9
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 9 |
|---|---|
Actelion Ltd.
 Actelion Ltd. Pharmaceuticals: MajorHealth Technology Develops, produces and markets pharmaceutical drugs | Health Technology |
Wellington Partners GmbH
 Wellington Partners GmbH Investment ManagersFinance Wellington Partners invests in companies located in Europe, the United States and Asia. The firm focuses on biotechnology, therapeutics, medical devices, diagnostics and digital health sectors. It provides financing for early and growth stage transactions with an investments size of EUR 2 - 20 million. The firm also acts as lead investor. | Finance |
Cancer Genetics, Inc.
 Cancer Genetics, Inc. Medical SpecialtiesHealth Technology Provides cancer diagnostics and clinical services | Health Technology |
Trigen Holdings AG
Trigen Holdings AG Miscellaneous Commercial ServicesCommercial Services Develops drugs focusing on thrombosis and vascular dysfunction | Commercial Services |
Immatics Biotechnologies GmbH
Immatics Biotechnologies GmbH BiotechnologyHealth Technology Operates as a bio technology company that develops and delivers T cell redirecting immunotherapies for treatment of cancer | Health Technology |
New York Philharmonic
New York Philharmonic Movies/EntertainmentConsumer Services Provides live theatrical presentations | Consumer Services |
Ruprecht-Karls-Universität Heidelberg
 Ruprecht-Karls-Universität Heidelberg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Geneva
 University of Geneva Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Symetis SA
 Symetis SA BiotechnologyHealth Technology Develops products for pediatric cardio-vascular applications | Health Technology |
